Table 2.
Multivariable Analysis of ICU-Acquired Weakness
| Variable | OR | 95% CI | P Value |
|---|---|---|---|
| Vasoactive medication | 3.2 | 1.29-7.95 | .01 |
| APACHE II | 1.08 | 1.01-1.15 | .02 |
| Sepsis | 0.91 | 0.32-2.62 | .85 |
| Hospital length of stay, d | 1.05 | 1.01-1.08 | .009 |
| Age, y | 1.03 | 1.0-1.05 | .03 |
| Ventilator use, d | 1.07 | 0.98-1.16 | .15 |
| Early mobilization | 0.38 | 0.17-0.85 | .02 |
| Mean arterial pressurea | 0.97 | 0.92-1.02 | .21 |
| Study group | 0.34 | 0.14-0.8 | .01 |
APACHE II = Acute Physiology and Chronic Health Evaluation II; OR = odds ratio for developing ICU-acquired weakness.
a
Median area under the curve of mean arterial pressure (mm Hg) during ICU stay.